The use of interferon beta in relapsing-remitting multiple sclerosis

被引:16
作者
Etheridge, LJ
Beverley, DW
Ferrie, C
McManus, E
机构
[1] York Hosp, York YO31 8HE, N Yorkshire, England
[2] Bradford Royal Infirm, Bradford BD9 6RJ, W Yorkshire, England
[3] Leeds Gen Infirm, Leeds, W Yorkshire, England
关键词
D O I
10.1136/adc.2003.040881
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
The use of interferon beta-1a to treat multiple sclerosis in a child of 7 years of age is discussed. To date, there is only one other published report of the use of interferon beta in a child as young as this. One year after commencing treatment she had shown significant clinical improvement, with a marked reduction in number of relapses. In her second year of treatment she suffered a major relapse from which she slowly recovered.
引用
收藏
页码:789 / 791
页数:3
相关论文
共 11 条
[1]   Interferon beta-1b and childhood multiple sclerosis [J].
Adams, AB ;
Tyor, WR ;
Holden, KR .
PEDIATRIC NEUROLOGY, 1999, 21 (01) :481-483
[2]   Early onset multiple sclerosis - A longitudinal study [J].
Boiko, A ;
Vorobeychik, G ;
Paty, D ;
Devonshire, V ;
Sadovnick, D .
NEUROLOGY, 2002, 59 (07) :1006-1010
[3]   Clinical benefits of interferon beta-1a in relapsing-remitting MS:: a phase IV study [J].
Fernández, O ;
Arbizu, T ;
Izquierdo, G ;
Martínez-Yélamos, A ;
Gata, JM ;
Luque, G ;
de Ramón, E .
ACTA NEUROLOGICA SCANDINAVICA, 2003, 107 (01) :7-11
[4]   Interferons in relapsing remitting multiple sclerosis: a systematic review [J].
Filippini, G ;
Munari, L ;
Incorvaia, B ;
Ebers, GC ;
Polman, C ;
D'Amico, R ;
Rice, GPA .
LANCET, 2003, 361 (9357) :545-552
[5]  
Francis G, 2001, NEUROLOGY, V56, P1628
[6]   Interferon-β treatment in patients with childhood onset multiple sclerosis [J].
Mikaelloff, Y ;
Moreau, T ;
Debouverie, M ;
Pelletier, J ;
Lebrun, C ;
Gout, O ;
Pedespan, JM ;
Van Hulle, C ;
Vermersch, P ;
Ponsot, G .
JOURNAL OF PEDIATRICS, 2001, 139 (03) :443-446
[7]  
National Institute for Clinical Excellence, 2002, BET INT GLAT AC TREA
[8]   A 6-year clinical and MRI follow-up study of patients with relapsing-remitting multiple sclerosis treated with interferon-beta [J].
Paolillo, A ;
Pozzilli, C ;
Giugni, E ;
Tomassini, V ;
Gasperini, C ;
Fiorelli, M ;
Mainero, C ;
Horsfield, M ;
Galgani, S ;
Bastianello, S ;
Buttinelli, C .
EUROPEAN JOURNAL OF NEUROLOGY, 2002, 9 (06) :645-655
[9]   CLINICAL DATA AND THE IDENTIFICATION OF SPECIAL FORMS OF MULTIPLE-SCLEROSIS IN 1271 CASES STUDIED WITH A STANDARDIZED DOCUMENTATION SYSTEM [J].
POSER, S ;
WIKSTROM, J ;
BAUER, HJ .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1979, 40 (2-3) :159-168
[10]   Multiple sclerosis in children under 6 years of age [J].
Ruggieri, M ;
Polizzi, A ;
Pavone, L ;
Grimaldi, LME .
NEUROLOGY, 1999, 53 (03) :478-484